Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study

Background This open-label pilot study is aimed to evaluate the efficacy and tolerability of the antidepressant duloxetine, which is effective for diabetic neuropathic pain, in the treatment of chronic oxaliplatin-induced peripheral neuropathy (OIPN).